新闻 > 经济
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China

药品审批新政落地 中国药企创新春天来了

2017-10-11 10:32:57   

药品审批新政落地

我国药企创新春天来了

缺医少药是中国老百姓面临的严峻事实。以抗癌新药为例,中国患者往往需要等待超过5年,才能用上国外新疗法。如今,这一局面将会得到有效扭转。

中国医药行业迎来重大利好政策。10月8日,中共中央办公厅和国务院办公厅联合印发《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》(以下简称《意见》)。这是继2015年8月《国务院关于改革药品医疗器械审评审批制度的意见》之后,又一个深化药品医疗器械审评审批制度改革的纲领性文件,对我国医药产业创新发展具有里程碑意义。

“作为医药创新企业我们倍感鼓舞,庆幸赶上了中国医药创新最好的时代。”贝达药业股份有限公司董事长兼CEO丁列明在接受科技日报记者采访时说。

丁列明表示,《意见》大力推进药品监管制度改革,有望进一步加快新药上市流程,满足中国广大老百姓的用药需求。

临床试验

机构资格由认定改为备案

“《意见》的核心就是鼓励创新,着力点在于解决公众的用药问题,让公众能用得上新药,用得上好药,当医生在给患者治病的过程当中能够有更多的选择。”9日,国家食品药品监督管理总局就《意见》相关情况举行发布会,该局副局长吴浈在会上说。

长期以来,药物审批的滞缓冗长,已很大程度制约药物创新,业界一直呼吁改革。

对此,国家食品药品监督管理总局药品、化妆品注册司司长王立丰表示,临床试验机构的资源相对紧缺,是制约我们药品创新发展的一个深层次问题。

“此次改革第一项就是将临床试验机构资格认定改为备案制,这是我们临床试验改革的一项重要内容。”王立丰说,大家都知道,药物研发最重要的一个环节就是临床试验,耗时时间长,投入成本高。当前,我国二级以上的医疗机构已经超过1万家,三级以上的医疗机构有2000多家,但是现在能够做药物临床试验的机构通过认定的只有600多家,特别是能够承担Ⅰ期临床试验的机构仅有100多家,某种程度上成为医药创新的瓶颈。

王立丰认为,目前临床试验机构的认定不能满足创新的需求,特别是现在临床机构还承担着大量的医疗任务,所以在临床机构里面如果能够分割出一些来承担药物临床试验,就显得尤为重要。临床试验机构由认定改成备案,这样可以减少环节,提高效率。

上一页1/3下一页
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China

相关阅读

404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
分享到:
0 0
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China

美图推荐

404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China

为您推荐

加载更多>>
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China
404 Not Found

404 Not Found

Sorry for the inconvenience.
Please report this message and include the following information to us.
Thank you very much!

URL: http://3g.china.com:8080/act/news/11155042/20171011/31558910.html
Server: cms-8-252
Date: 2024/11/15 11:12:06

Powered by China
China